CSB 4.15(3)(f)(f) The number of patients to whom the practitioner prescribed a monitored prescription who satisfy any of the criteria identified in sub. (4).
CSB 4.15(4)(4)The board may include any of the following factors when determining whether circumstances indicate suspicious or critically dangerous conduct or practices of a patient:
CSB 4.15(4)(a)(a) The number of practitioners from whom the patient has obtained a prescription for a monitored prescription drug.
CSB 4.15(4)(b)(b) The number of pharmacies from where the patient was dispensed a monitored prescription drug.
CSB 4.15(4)(c)(c) The number of prescriptions for a monitored prescription drug obtained by the patient.
CSB 4.15(4)(d)(d) The number of monitored prescription drug doses dispensed to the patient.
CSB 4.15(4)(e)(e) Whether the monitored prescription drugs dispensed to the patient include dangerous levels of any drug.
CSB 4.15(4)(f)(f) The number of times the patient is prescribed or dispensed a monitored prescription drug before the previously dispensed amount of the same or a similar monitored prescription drug would be expected to end.
CSB 4.15(4)(g)(g) The payment methodology used by the patient to obtain controlled substances at a pharmacy.
CSB 4.15(5)(5)Upon determining that circumstances indicate suspicious or critically dangerous conduct or practices of a pharmacy, practitioner, or patient, the Board may disclose monitored prescription drug history reports, audit trails, and PDMP data to any of the following:
CSB 4.15(5)(a)(a) A relevant patient.
CSB 4.15(5)(b)(b) A relevant pharmacist or practitioner.
CSB 4.15(5)(c)(c) A relevant state board or agency.
CSB 4.15(5)(d)(d) A relevant agency of another state.
CSB 4.15(5)(e)(e) A relevant law enforcement agency.
CSB 4.15(6)(6)Upon determining that a criminal violation may have occurred, the board may refer a pharmacist, pharmacy, or practitioner to the appropriate law enforcement agency for investigation and possible prosecution. The board may disclose monitored prescription drug history reports, audit trails, and PDMP data to the law enforcement agency as part of the referral.
CSB 4.15 HistoryHistory: CR 15-101: cr. Register June 2016 No. 726, eff. 7-1-16; CR 17-028: am. (1), (5) (intro.), cr. (6) Register December 2017 No. 744, eff. 1-1-18.